Pfizer Posted August 12, 2026

Vice President, Obesity US Market Access (Strategy & Marketing, Contracting & Pricing)

New York City, United States Full time
Market Access Executive/VP

Pfizer is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

Role Summary

The VP, Obesity U.S. Market Access reports directly to the VP, U.S. Market Access – Primary Care. This is a new VP-level role established to build dedicated market access capabilities for Pfizer's Obesity portfolio.

Obesity represents a significant growth priority for Pfizer, and the category’s access, patient, and payer dynamics differ materially from Pfizer’s existing brand-support models. This role is being established to build those capabilities directly, rather than extend an existing coverage model to a new category.

This role directly owns access marketing strategy and execution, and owns contracting and pricing strategy for obesity assets, which is executed in coordination with core USMA functions, including strategy, contracting, account management, and market access operations. Throughout execution, the VP ensures work stays aligned with Obesity brand and portfolio objectives.

The VP interfaces directly with the Primary Care BU, partnering closely with the Obesity Franchise Lead on business goals and balancing access investment against gross-to-net (GTN) to maximize net trade sales. The VP is also the single point of contact for Obesity across market access and patient services, reflecting the distinct, higher-touch engagement model Obesity requires as a new frontier for the portfolio.

Role Responsibilities

1. Obesity Access Strategy & Execution Ownership

Own end-to-end market access strategy for Obesity assets, from early strategy development through execution, including access strategy, payer marketing, pricing, and contracting in one coherent plan

Define the payer value proposition, messaging, and positioning for Obesity assets, tailored to the access barriers and customer dynamics specific to the Obesity category

Set and execute pricing and contracting strategy for Obesity assets, balancing access investment against GTN to maximize net trade sales

Build and continuously refine the Obesity market access playbook as the category, competitive landscape, and payer response evolve

Define and monitor access performance metrics for Obesity, including access quality, access speed, and GTN performance relative to plan

2. BU Partnership & Business Co-Ownership

Serve as the direct partner to the Obesity Franchise Lead within the Primary Care BU, jointly owning the balance between brand growth objectives and access/GTN discipline

Translate Obesity brand P&L objectives and business goals into access, pricing, and contracting priorities

Flag trade-offs between revenue maximization and GTN discipline to the Franchise Lead and USMA-Primary VP, ensuring access decisions reflect enterprise-level economics rather than brand-pressure-driven discounting

Represent Obesity access needs into USMAPPS leadership, escalating resourcing gaps or strategic misalignment as the category scales

3. Integrated Access & Patient Services Leadership

Serve as the single point of accountability for the Obesity Franchise, bringing together market access and patient services strategies into one coordinated approach that advances patient, customer, and business outcomes.

Partner closely with Patient Services on the patient journey, jointly shaping affordability, hub, adherence, and support strategies to ensure patients can access and remain on therapy.

Lead the evolution of Obesity patient support capabilities, identifying unique category dynamics, direct patient engagement, affordability considerations, and emerging reimbursement pathways require innovative models beyond traditional approaches.

4. Launch & Market Shaping Readiness

Own the access portion of the strategic brand plan for Obesity pipeline assets, ensuring access strategy is integrated into brand planning from early lifecycle stages

Build early market-shaping strategy: proactively engaging payers, health systems, and other stakeholders ahead of formulary decisions rather than reacting to them

Identify and close access readiness gaps for pipeline Obesity assets, including payer coverage, reimbursement pathways, and formulary positioning

Define multi-year market access plans for the Obesity pipeline, incorporating GTN inputs into long-range financial planning

5. Team Leadership & Talent

Lead and develop a dedicated Obesity team, including colleagues covering Access Marketing Strategy and Contracting & Pricing

Coach team members to operate as strategic owners of their piece of the Obesity portfolio, not coordinators

Build the Obesity capability and talent pipeline as the category and team are expected to scale over time

Participate as a member of the USMA-Primary leadership structure, contributing Obesity-specific perspective to broader Primary strategy

Model Pfizer values and leader behaviors

Basic Qualifications

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Bachelor's degree required

12+ years of experience in the healthcare sector, including demonstrated success in market access, payer strategy, or brand-level access roles

Deep understanding of the US healthcare environment, including payer dynamics, formulary mechanics, and GTN economics

Demonstrated experience developing and executing integrated market access plans spanning payer marketing, pricing, and contracting strategy

Prior experience in Obesity, cardiometabolic, or another high-growth/high-visibility launch category

Experience operating in a fast-evolving or newly established category, with the ability to build strategy and capability without an established playbook

Demonstrated business and financial acumen, including the ability to understand brand P&L dynamics and translate them into access investment and GTN trade-off decisions

Strong influence and negotiation skills, with the ability to build trust and drive alignment with senior BU stakeholders

Previous supervisory and people management experience

Demonstrated agility with ambiguity and organizational change

Preferred Qualifications

MBA or advanced degree in a healthcare-related or business field

Experience partnering directly with brand or franchise leadership on integrated business and access strategy

Experience with direct-to-patient or direct-to-consumer engagement models

Familiarity with patient affordability and hub services program design

Other Job Details:

Last Date to Apply for Job: August 25th, 2026

Domestic travel up to ~25%, based on business needs

NOT eligible for Relocation Package

This position is hybrid and requires working from New York headquarters 2 to 3 days per week

#LI-PFE


The annual base salary for this position ranges from $274,000.00 to $456,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 30.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.



 Relocation assistance may be available based on business needs and/or eligibility.


 Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN, O-1, H-1B, etc.) is not available for this role now or in the future.


 Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.  These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure.  Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act.  Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government.  If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.


 EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.  Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.  Pfizer is an E-Verify employer.  This position requires permanent work authorization in the United States.

Pfizer endeavors to make   www.pfizer.com/careers   accessible to all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process and/or interviewing, please email   [email protected] . This is to be used solely for accommodation requests with respect to the accessibility of our website, online application process and/or interviewing. Requests for any other reason will not be returned.


 To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on  Pfizer Careers .


Market Access


Job details

Seniority
Executive/VP
Function
Market Access
Therapeutic area
Not listed
Location
New York City, United States
Employment type
Full time

How this role compares

Computed from every other active Market Access role in our database, not just this employer's listings.

We currently track 5 comparable Executive/VP Market Access roles across 4 biopharma companies.

5Comparable roles tracked
4Currently active
4Companies hiring similar roles
1Countries represented

Salary context

2 of 5 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject $274,000/yr – $456,600/yr
Lowest disclosed · Senior Director, US Vaccines Contracting and Pricing · Pfizer $214,900/yr – $358,100/yr
Highest disclosed · Senior Director, PAVE Access Strategy & Marketing · Pfizer $214,900/yr – $358,100/yr
Peer group range $286,500 – $286,500 (median $286,500)

Where these roles are based

Top locations among the 5 comparable roles

United States5

Seniority mix

5 of 5 peers have a known seniority level

Senior Director4
Executive/VP1

Therapeutic area mix

3 of 5 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology1
Vaccines & Infectious Disease1
Neuroscience1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

60%similar
E.R. Squibb & Sons,L.L.C. Princeton, United States Executive/VP
Same function Same seniority Same country
50%similar
Pfizer New York City, United States Senior Director
Same function Adjacent seniority Same country
50%similar
Biogen Cambridge, United States Senior Director
Same function Adjacent seniority Same country
50%similar
AstraZeneca Boston, Massachusetts, United States of America Senior Director
Same function Adjacent seniority Same country
50%similar
Pfizer New York City, United States Senior Director
Same function Adjacent seniority Same country

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

60%
Executive Director, US Access Strategy - Oncology
E.R. Squibb & Sons,L.L.C. · Princeton, United States · Executive/VP
Function Therapeutic area Seniority Country
50%
Senior Director, US Vaccines Contracting and Pricing
Pfizer · New York City, United States · Senior Director
Function Therapeutic area Adjacent seniority Country
50%
Senior Director, Field Reimbursement
AstraZeneca · Boston, Massachusetts, United States of America · Senior Director
Function Therapeutic area Adjacent seniority Country
50%
Senior Director, PAVE Access Strategy & Marketing
Pfizer · New York City, United States · Senior Director
Function Therapeutic area Adjacent seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.